![Carmen Betancourt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carmen Betancourt
Conseiller Juridique Général chez CIDARA THERAPEUTICS, INC.
Postes actifs de Carmen Betancourt
Sociétés | Poste | Début | Fin |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2014 | - |
Golden Gate Bioventures LLC | Corporate Officer/Principal | 01/12/2013 | - |
Historique de carrière de Carmen Betancourt
Anciens postes connus de Carmen Betancourt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Conseiller Juridique Général | 01/01/2013 | 01/01/2014 |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Conseiller Juridique Général | 01/01/2008 | 01/01/2009 |
HUMANIGEN, INC. | Conseiller Juridique Général | 01/01/2006 | 01/01/2007 |
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | 01/01/2002 | 01/01/2006 |
TITAN PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2001 | 01/01/2002 |
Coulter Pharmaceuticals, Inc.
![]() Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Conseiller Juridique Général | 01/01/1997 | 01/01/2000 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | 01/01/1992 | 01/01/1997 |
Formation de Carmen Betancourt
Golden Gate University | Masters Business Admin |
University of California, Davis | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Opérationnelle
General Counsel | 8 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
TITAN PHARMACEUTICALS, INC. | Health Technology |
HUMANIGEN, INC. | Health Technology |
CIDARA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Coulter Pharmaceuticals, Inc.
![]() Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
VaxGen, Inc.
![]() VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Cerexa, Inc.
![]() Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Health Technology |
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Golden Gate Bioventures LLC |
- Bourse
- Insiders
- Carmen Betancourt
- Expérience